Worldwide, more than 55 million people suffer from dementia caused by Alzheimer's Disease (AD) and other conditions that destroy cells in the brain and nervous system. While there is no treatment to control or manage these neurodegenerative conditions, investigators have identified a new and promising drug to treat AD. The drug--and their approach by identifying a new target in the brain -- showed promising results in mouse models of AD.